Market Overview:
Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Forecast Years | 2023-2033 |
| Historical Years | 2017-2022 |
Market Size in 2022 | US$ 6,449.9 Million |
Market Forecast in 2033 | US$ 9,770.1 Million |
Market Growth Rate (2023-2033) | 3.85% |
According to the IMARC Group, the chronic lower back pain market exhibited a market size of US$ 6,449.9 Million in the year 2022 and is projected at a CAGR of 3.85% during 2023-2033. This can be attributed to the emerging popularity of non-opioid pain management techniques, such as physical therapy, acupuncture, cognitive behavioral therapy, etc., for reducing pain without the risks associated with opioid use, including addiction and withdrawal symptoms.
The report offers a comprehensive analysis of the chronic lower back pain market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the chronic lower back pain market.
Request for a Sample of this Report: https://www.imarcgroup.com/chronic-lower-back-pain-market/requestsample
Chronic Lower Back Pain Market Trends:
Chronic lower back pain is a debilitating condition characterized by persistent pain in the lower back that lasts for more than 12 weeks despite attempts to treat or manage it. Chronic lower back pain continues to drive significant growth in the healthcare market. Several factors are contributing to the expansion of this market, and understanding the drivers is essential for stakeholders and healthcare professionals alike. To begin with, the aging population is a prominent driver of the chronic lower back pain market. As people grow older, the risk of developing chronic conditions like osteoarthritis and degenerative disc disease increases. These age-related factors lead to a higher prevalence of chronic lower back pain, thereby fueling the demand for treatments and therapies.
Moreover, lifestyle changes and sedentary habits have become prevalent in modern society, leading to a surge in musculoskeletal problems. Prolonged hours of sitting, poor posture, and limited physical activity are contributing factors to the rising incidence of lower back pain. As a result, individuals are seeking medical interventions and pain management solutions, stimulating market growth. Furthermore, advancements in medical technology and treatment options are propelling the chronic lower back pain market forward. Minimally invasive procedures, such as spinal cord stimulation and epidural injections, are offering patients effective and less invasive alternatives to surgery. The innovations not only improve patient outcomes but also drive market expansion as healthcare providers adopt these state-of-the-art techniques.
Countries Covered:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country:
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the chronic lower back pain market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the chronic lower back pain market
• Reimbursement scenario in the market
• In-market and pipeline drugs
This report also provides a detailed analysis of the current chronic lower back pain marketed drugs and late-stage pipeline drugs.
In-Market Drugs:
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance
Competitive Landscape With Key Players:
The competitive landscape of the chronic lower back pain market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of the Key Players:
- Camurus
- Scilex Pharmaceuticals, In
- AnGes
- Eli Lilly and Company
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7232&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/
